India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Metabolic hypogonadism, a condition marked by low testosterone levels and frequently seen in obese individuals, contributes to worsening metabolic health and an increased risk of type 2 diabetes.

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

The illicit supply of unregulated weight loss drugs is becoming an ‘emerging concern’ for Police Scotland and the Scottish Government.